Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: The Cyclofa-Lune study

Lupus

Volumn 19, Issue 11, 2010, Pages 1281-1289

  Závada, Jakub ^a   Pesickova S S ^a   Rysava R ^a   Olejarova M ^a   Horak P ^b   Hrncir Z ^a   Rychlik I ^a   Havrda, M ^a   Vitova J ^c   Lukac J ^d   Rovensky J ^d   Tegzova, D ^a   Bohmova J ^e   Zadrazil J ^b   Hana J ^c   Dostal C ^a   Tesar, V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c Department of Internal Medicine Hospital ^*  (Czech Republic)

^d National Institute of Rheumatology   (Slovakia)

^e ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Cyclosporine A; lupus nephritis; systemic lupus erythematosus; treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE;

ADULT; AMENORRHEA; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS FILTRATION RATE; GRAND MAL SEIZURE; HAIR LOSS; HERPES ZOSTER; HIRSUTISM; HUMAN; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; PERIANAL ABSCESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEPSIS; SIDE EFFECT; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION; URINE SEDIMENT;

ADULT; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; LUPUS NEPHRITIS; MALE; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649756235     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310371155     Document Type: Article

References (27)

1. Huong DL, Papo T., Beaufils H., et al. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) 1999 ; 78: 148-166.
2. Estes D., Christian CL The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971 ; 50: 85-95.
3. Appel GB, Cohen DJ, Pirani CL, et al. Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med 1987 ; 83: 877-885.
4. Steinberg AD, Steinberg SC Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 1991 ; 34: 945-950.
5. Donadio Jr JV, Holley KE, Ferguson RH, et al. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 1978 ; 299: 1151-1155.
6. Austin III HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986 ; 314: 614-619.
7. Boumpas DT, Austin III HA, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992 ; 340: 741-745.
8. Boumpas DT, Austin III HA, Fessler BJ, et al. Systemic lupus erythematosus: emerging concepts. Part I. Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995 ; 122: 940-950.
9. Ferraccioli GF, Tomietto P., De Santis M. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases. Ann N Y Acad Sci 2005 ; 1051: 658-665.
10. Isenberg DA, Snaith ML, Morrow WJ, et al. Cyclosporin A for the treatment of systemic lupus erythematosus. Int J Immunopharmacol 1981 ; 3: 163-169.
11. Manger K., Kalden RJ, Manger R. Cyslosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheum 1996 ; 35: 669-675.
12. Dammaco F., Della Casa Alberighi O., Ferraccioli G., et al. Ciclosporine A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus. Int J Clin Lab Res 2000 ; 30: 67-73.
13. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, et al. A randomised trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 1999 ; 56: 2220-2226.
14. Schieppati A., Mosconi L., Perna A., et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993 ; 329: 85-89.
15. Cattran DC, Greenwood C., Bernstein RS, et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 1995 ; 47: 1130-1135.
16. Dostál C., Tesar V., Rychlík I., et al. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study. Lupus 1998 ; 7: 29-36.
17. Rihova Z., Vankova Z., Maixnerova D., et al. Treatment of lupus nephritis with cyclosporine-an outcome analysis. Kidney Blood Press Res 2007 ; 30: 124-128.
18. Favre H., Miescher PA, Huang YP, et al. Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 1989 ; 9 (Suppl): 57-60.
19. Hussein MM, Mooij JMV, Roujouleh H. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin Nephrol 1993 ; 40: 160-163.
20. Lukac J., Rovensky J., Rauova L. Cyclosporine A in the treatment of systemic lupus erythematosus with lupus nephritis. Arthritis Rheum 1995 ; 52: 116.
21. Manger K., Kalden JR, Manger B. Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 1996 ; 35: 669-675.
22. Tam LS, Li EK, Leung CB, et al. Long-term treatment of lupus nephritis with cyclosporin A. Q J Med 1998 ; 91: 573-580.
23. Fu LW, Yang LY, Chen WP, et al. Clinical efficacy of Cyclosporin A Neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. Br J Rheumatol 1998 ; 37: 217-221.
24. Austin HA, Illei GG, Braun MJ, et al. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol 2009 ; 20: 901-911.
25. Moroni G., Doria A., Mosca M., et al. A randomized pilot trial comparing cyclosporine versus azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol 2006 ; 1: 925-932.
26. Hansen JM, Fogh-Andersen N., Christensen NJ, et al. Cyclosporine-induced hypertension and decline in renal function in healthy volunteers. J Hypertens 1997 ; 15: 319-326.
27. Boumpas DT, Balow JE Outcome criteria for lupus nephritis trials: a critical overview. Lupus 1998 ; 7: 622-629.